Nuveen
INSP icon

Nuveen’s Inspire Medical Systems INSP Stock Holding History

Nuveen’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12M Sell
70,046
-15,123
-18% -$717K ﹤0.01% 2351
2026
Q1 		$4.39M Sell
85,169
-74,252
-47% -$5.2M ﹤0.01% 1932
2025
Q4 		$14.7M Buy
159,421
+111,569
+233% +$10.7M ﹤0.01% 1325
2025
Q3 		$3.55M Sell
47,852
-165
-0.3% -$16.7K ﹤0.01% 2070
2025
Q2 		$6.23M Sell
48,017
-88,605
-65% -$12.8M ﹤0.01% 1772
2025
Q1 		$21.8M Sell
136,622
-16,846
-11% -$3.05M 0.01% 1079
2024
Q4 		$28.4M Sell
153,468
-27,132
-15% -$5.27M 0.01% 955
2024
Q3 		$38.1M Buy
180,600
+41,384
+30% +$7.19M 0.01% 801
2024
Q2 		$18.6M Buy
139,216
+4,265
+3% +$807K 0.01% 1178
2024
Q1 		$29M Buy
134,951
+36,458
+37% +$7.15M 0.01% 934
2023
Q4 		$20M Sell
98,493
-28,441
-22% -$4.61M 0.01% 1156
2023
Q3 		$25.2M Buy
126,934
+18,846
+17% +$4.75M 0.01% 906
2023
Q2 		$35.1M Buy
108,088
+14,820
+16% +$4.23M 0.01% 732
2023
Q1 		$21.8M Sell
93,268
-4,618
-5% -$1.17M 0.01% 984
2022
Q4 		$24.7M Sell
97,886
-10,969
-10% -$2.34M 0.01% 903
2022
Q3 		$19.3M Buy
108,855
+9,929
+10% +$2M 0.01% 1036
2022
Q2 		$18.1M Sell
98,926
-7,943
-7% -$1.58M 0.01% 1106
2022
Q1 		$24.8M Sell
106,869
-2,702
-2% -$617K 0.01% 1046
2021
Q4 		$25.2M Sell
109,571
-9,012
-8% -$2.2M 0.01% 1081
2021
Q3 		$27.6M Sell
118,583
-11,329
-9% -$2.36M 0.01% 1043
2021
Q2 		$25.1M Buy
129,912
+2,559
+2% +$508K 0.01% 1192
2021
Q1 		$26.4M Buy
127,353
+1,212
+1% +$258K 0.01% 1118
2020
Q4 		$23.7M Sell
126,141
-5,627
-4% -$920K 0.01% 1144
2020
Q3 		$17M Sell
131,768
-11,147
-8% -$1.23M 0.01% 1168
2020
Q2 		$12.4M Buy
142,915
+77,488
+118% +$5.96M 0.01% 1340
2020
Q1 		$3.94M Buy
65,427
+9,017
+16% +$667K ﹤0.01% 1846
2019
Q4 		$4.19M Sell
56,410
-1,032
-2% -$66.3K ﹤0.01% 2085
2019
Q3 		$3.5M Sell
57,442
-694
-1% -$45.7K ﹤0.01% 2140
2019
Q2 		$3.53M Buy
+58,136
New +$3.13M ﹤0.01% 2170

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nuveen's INSP Position: Q2 2026 in Review

Nuveen reduced its Inspire Medical Systems (INSP) stake by 18% in Q2 2026, selling an estimated $717K and leaving 70,046 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2351.

Nuveen first reported a position in INSP in Q2 2019 and has held it in 29 quarters since. The position peaked at $38.1M in Q3 2024. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Nuveen held 70,046 shares of Inspire Medical Systems worth $3.12M as of Q2 2026.
  • Nuveen sold 15,123 Inspire Medical Systems shares in Q2 2026, an estimated $717K.
  • Inspire Medical Systems made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2351 holding.
  • Nuveen first reported a position in Inspire Medical Systems in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Inspire Medical Systems position peaked at $38.1M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.